The COVID19 pandemic has highlighted the need for having well-resourced pathogen sequencing facilities. Public awareness of genome sequencing was increased by the media coverage of ‘variants’, but there is little understanding of sequencing among affected communities, policymakers, government personnel and academic stakeholders.
The ‘Covid Kurakani’ project, funded by Wellcome Trust, is a supplement to the COVID genomic surveillance project, Epidemic Intelligence (EI). Covid Kurakani aims to engage stakeholders in a dialogue so that the Epidemic Intelligence research team, researchers, public health professionals and policy makers can understand the perspectives, concerns and perceived benefits of sequencing to inform the design of future sequencing activities. The Covid Kurakani project will also build a foundation through dialogue of understanding of genomic science and its application in pandemics among stakeholders. This will help improve the accuracy of communication of project findings and context to stakeholders for the Epidemic Intelligence project and other pathogen sequencing studies conducted in Nepal.
The panel discussion series will comprise of dialogues among stakeholders of the EI project to improve understanding of the need for, and importance of the pathogen genomic sequencing in the response to emerging diseases.
Participants of the Epidemic Intelligence research; District health officials and healthcare workers from Epidemic Intelligence partner hospitals; Academics and laboratory staff from institutions considering developing sequencing capacity and public stakeholders. Also, public audience of "This Morning Live" of Galaxy 4K Television.